Update on radiological imaging of renal cell carcinoma

BJU International

Volumn 99, Issue 5 B, 2007, Pages 1217-1222

  Coll, Deirdre M ^a,b   Smith, Robert C ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Computed tomography; Contrast agents; Magnetic resonance imaging; Staging; Ultrasonography

Indexed keywords

GADOLINIUM;

CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HUMAN; KIDNEY CARCINOMA; KIDNEY FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; TECHNOLOGY; THREE DIMENSIONAL IMAGING; ULTRASOUND;

CARCINOMA, RENAL CELL; CONTRAST MEDIA; DIAGNOSTIC IMAGING; HUMANS; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34247236767     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.06824.x     Document Type: Review

References (26)

1. Jemal A, Murray T, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30
2. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003; 30: 843-52
3. Tsui KH, Shvart O, Smith RB, Figlin R, de Kirnion JB, Belldegrun A. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol 2000; 163: 426-30
4. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996; 335: 865-75
5. Jamis-Dow CA, Choyke PL, Jennings SB, Linehan WM, Thakore KN, Walther MM. Small (< or = 3-cm) renal masses: detection with CT versus US and pathologic correlation. Radiology 1996; 198: 785-8
6. Shapiro RS, Wagreich J, Parsons RB, Stancato-Pasik A, Yeh HC, Lao R. Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography. AJR Am J Roentgenol 1998; 171: 1203-6
7. Jespersen SK, Wilhjelm JE, Sillesen H. Multi-angle compound imaging. Ultrason Imaging 1998; 20: 81-102
8. Ascenti G, Zimbaro G, Mazziotti S, Gaeta M, Settineri N, Scribano E. Usefulness of power Doppler and contrast-enhanced sonography in the differentiation of hyperechoic renal masses. Abdom Imaging 2001; 26: 654-60
9. Robbin ML, Lockhart ME, Barr RG. Renal imaging with ultrasound contrast: current status. Radiol Clin North Am 2003; 41: 963-78
10. Yamashita Y, Takahashi M, Watanabe O et al. Small renal cell carcinoma: pathologic and radiologic correlation. Radiology 1992; 184: 493-8
11. Sheth S, Scatarige JC, Horton KM, Corl FM, Fishman EK. Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector CT and three-dimensional CT. Radiographics 2001; 21: S237-54
12. Herts BR, Coll DM, Novick AC et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am J Roentgenol 2002; 178: 367-72
13. Sheir KZ, El-Azab M, Mosbah A, El-Baz M, Shaaban AA. Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol 2005; 174: 451-5
14. Catalano C, Fraioli F, Laghi A et al. High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma. AJR Am J Roentgenol 2003; 180: 1271-7
15. Yoon J, Herts BR. Staging renal cell carcinoma with helical CT: the revised 1997 AJCC and UICC TNM criteria. Crit Rev Comput Tomogr 2003; 44: 229-49
16. Hallscheidt P, Pomer S, Roeren T, Kauffmann GW, Staehler G. [Preoperative staging of renal cell carcinoma with caval thrombus: is staging in MRI justified? Prospective histopathological correlated study]. Urologe A 2000; 39: 36-40
17. Myneni L, Hricak H, Carroll PR. Magnetic resonance imaging of renal carcinoma with extension into the vena cava: staging accuracy and recent advances. Br J Urol 1991; 68: 571-8
18. Glockner JF, Hu HH, Stanley DW, Angelos L, King K. Parallel MR imaging: a user's guide. Radiographics 2005; 25: 1279-97
19. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006; 21: 1104-8
20. Marckmann P, Skov L, Rossen K et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006; 17: 2359-62
21. Thomsen HS. Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur Radiol 2006;16: 2619-21
22. Ho VB, Allen SF, Hood MN, Choyke PL. Renal masses: quantitative assessment of enhancement with dynamic MR imaging. Radiology 2002; 224: 695-700
23. Roy C, Sauer B, Lindner V, Lang H, Saussine C, Jacqmin D. MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses. Eur Radiol 2007; 17: 193-200
24. Hallscheidt PJ, Bock M, Riedasch G et al. Diagnostic accuracy of staging renal cell carcinomas using multidetector-row computed tomography and magnetic resonance imaging: a prospective study with histopathologic correlation. J Comput Assist Tomogr 2004; 28: 333-9
25. Kang DE, White RL Jr, Zuger JH, Sasser HC, Teigland CM. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol 2004; 171: 1806-9
26. Jones TD, Eble JN, Cheng L. Application of molecular diagnostic techniques to renal epithelial neoplasms. Clin Lab Med 2005; 25: 279-303